Skip to content

Evaluation of the Efficacy of CURE-EX Treatment in Onychomycosis

Evaluation of the Efficacy of CURE-EX Treatment in Onychomycosis

Status
UNKNOWN
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02436291
Enrollment
50
Registered
2015-05-06
Start date
2014-10-31
Completion date
2015-12-31
Last updated
2015-05-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Onychomycosis

Brief summary

Open label study to evaluate the efficacy of CURE-EX device in the treatment of onychomycosis.

Detailed description

Each affected nail will be treated twice daily for 24-30 weeks. Efficacy will be evaluated by measuring the growth of healthy nail.

Interventions

DEVICECURE-EX device

Treatment with CURE-EX device twice daily for 24-30 weeks.

Sponsors

MB Mazor Ltd.
Lead SponsorINDUSTRY

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 75 Years
Healthy volunteers
No

Inclusion criteria

1. Subjects diagnosed with clinical and mycological onychomycosis (by culture and smear). 2. Subjects did not receive topical antifungal treatment during the 14 days prior to commencing the study. 3. Subjects did not receive any systemic antifungal treatment during the 3 months prior to the start of the study.

Exclusion criteria

1. lunula infected with onychomycosis. 2. Pregnant or breast feeding female.

Design outcomes

Primary

MeasureTime frameDescription
Nail cure as measured by measured by length of healthy nail of at least 5 mm24-30 weeksCure measured by length of healthy nail of at least 5 mm
Nail cure as measured by culture and smear24-30 weeksNail culture and smear

Countries

Israel

Contacts

Primary ContactOfer Mazor
ofmazor@gmail.com972-52-8566789

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026